MÅLOV, Denmark, Nov 21 - Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as
its established diabetes drugs come under price pressure, particularly in the United States.
MÅLOV, Denmark, Nov 21 (Reuters)- Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for
its established diabetes drugs come under pressure, particularly in the United States.
Not exact matches
May 20, 2015 Study adds
diabetes drug with anti-cancer effect to ovarian cancer treatment Several recent studies have suggested that metformin, an
established drug developed to treat patients with type II
diabetes, may provide significant benefits, including increased survival, to patients being treated for advanced cancers.
The fact that statin
drugs cause side effects is well
established - there are now 900 studies proving their adverse effects, which run the gamut from muscle problems to
diabetes, to birth defects and increased cancer risk.